Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
								
																		
									
																											
																		
									
																											
																		
									
										
											Monoisotopic mass 
										
										
											320.125988372										
									 
																											
									
																		
									
										
											InChI 
										
										
											InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+										
									 
																		
																		
										
											InChI Key 
										
										
											InChIKey=HPNSFSBZBAHARI-RUDMXATFSA-N										
									 
																											
																		
										
											IUPAC Name 
										
										
											(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid										
									 
																											
																		
										
											Traditional IUPAC Name 
										
										
											mycophenolic acid										
									 
																											
									
																		
										
											SMILES 
										
										
											COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C										
									 
																		
																		
									
																		
																		
																		
																		
																		
																											
																		
																											
																		
																											
																		
										
											pKa (strongest acidic) 
										
										
											3.57										
									 
																											
																		
										
											pKa (Strongest Basic) 
										
										
											-4.1										
									 
																											
																		
																											
																		
										
											Refractivity 
										
										
											85.23 m3·mol-1
										
									 
																			  
		  
																		
																											
																		
																		
									
																		
																		
																		
																		
																		
																		
																		
																		
											  
		  
								 
							 	
														
															
								 Dược Lực Học : 
								
									Mycophenolic acid is an antibiotic substance derived from Penicillium stoloniferum. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase. Mycophenolic acid is important because of its selective effects on the immune system. It prevents the proliferation of T-cells, lymphocytes, and the formation of antibodies from B-cells. It also may inhibit recruitment of leukocytes to inflammatory sites.									
							
														
															
								 Cơ Chế Tác Dụng : 
								
									Mycophenolic acid is an an immunosuppresant drug and potent anti-proliferative, and can be used in place of the older anti-proliferative azathioprine. It is usually used as part of triple therapy including a calcineurin inhibitor (ciclosporin or tacrolimus) and prednisolone. It is also useful in research for the selection of animal cells that express the E. coli gene coding for XGPRT (xanthine guanine phosphoribosyltransferase).								
								
									Mycophenolic acid is a potent, selective, uncompetitive, and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Because T- and B-lymphocytes are critically dependent for their proliferation on de novo synthesis of purines, whereas other cell types can utilize salvage pathways, mycophenolic acid has potent cytostatic effects on lymphocytes. Mycophenolic acid inhibits proliferative responses of T- and B-lymphocytes to both mitogenic and allospecific stimulation. Addition of guanosine or deoxyguanosine reverses the cytostatic effects of mycophenolic acid on lymphocytes. Mycophenolic acid also suppresses antibody formation by B-lymphocytes. Mycophenolic acid prevents the glycosylation of lymphocyte and monocyte glycoproteins that are involved in intercellular adhesion to endothelial cells and may inhibit recruitment of leukocytes into sites of inflammation and graft rejection.								
							
														
															
								 Dược Động Học  : 
								
									▧ Absorption : 
Bioavailability following oral administration of Myfortic delayed-release tablet ranges from 70-95%
▧ Volume of Distribution : 
* 54 ± 25 L
▧ Protein binding : 
>98%
▧ Metabolism : 
Mycophenolic acid is metabolized mainly by glucuronyl transferase to glucuronidated metabolites, predominantly the phenolic glucuronide, mycophenolic acid glucuronide (MPAG). MPAG does not manifest pharmacological activity. The acyl glucuronide minor metabolite has pharmacological activity similar to mycophenolic acid. The AUC ratio of Mycophenolic acid:MPAG:acyl glucuronide is approximately 1:24:0.28 at steady state.
▧ Half Life : 
The mean elimination half-life for mycophenolic acid ranges from 8-16 hours, while that of the MPAG metabolite ranges from 13-17 hours.
▧ Clearance : 
* 140 +/- 30 mL/min [Stable renal transplant patients]								
	
							 
														
														
								 Độc Tính : 
								
									Oral (LD50): Acute: 352 mg/kg [Rat], 1000 mg/kg [Mouse], and >6000 mg/kg [Rabbit]. Possible signs and symptoms of acute overdose could include the following: hematological abnormalities such as leukopenia and neutropenia, and gastrointestinal symptoms such as abdominal pain, diarrhea, nausea and vomiting, and dyspepsia.									
							
														
							
																					
								 Chỉ Định : 
								
									For the prophylaxis of organ rejection in patients receiving allogeneic renal transplants, administered in combination with cyclosporine and corticosteroids.								
							
	
														
									
							
							
								 Tương Tác Thuốc : 
																
																		
									- 
										Trastuzumab
										
											Trastuzumab may increase the risk of neutropenia and anemia. Monitor closely for signs and symptoms of adverse events.										
									
- 
										Valganciclovir
										
											The excretion rates of Valganciclovir and/or Mycophenolic acid may decrease. Monitor for increased serum concentrations and toxicity of both agents.										
									
 								
							
							
							
							
								
								 Liều Lượng & Cách Dùng : 
								
									Tablet, coated - Oral								
							
	
							
														
														
							
																						
								 Dữ Kiện Thương Mại 
								
																											
										
											Giá thị trường
										
										
											
																							- 
													
													Giá bán buôn : USD >3.85 Đơn vị tính : tablet 
- 
													
													Giá bán buôn : USD >7.69 Đơn vị tính : tablet 
- 
													
													Giá bán buôn : USD >8.0 Đơn vị tính : tab 
 
									 
																		
																											
																		
																											
											  
		  
								 
							 	
							
							
														
							
						
							
																													
								 Tài Liệu Tham Khảo Thêm 
								
																		
																		
																		
																		
																		
																		
										
											National Drug Code Directory